Intensity Therapeutics, The Ottawa Hospital And Ontario Institute For Cancer Research Report INT230-6 Demonstrates Tumor Necrosis And Immune Activation In Early Stage Breast Cancers
Significant Necrosis Demonstrated in Invasive Ductal and Lobular Cancers, Which are Normally Resistant to Chemotherapy.
Significant Necrosis from a Single Injection of up to 100% of a Tumor was Observed During the